-
Scottish Medicines Consortium Approves Ocrevus for Treating PPMS
Ocrevus (ocrelizumab) has been approved as a treatment for early, inflammatory primary progressive multiple sclerosis (PPMS) in Scotland. Read more about it.
Have you been treated with Ocrevus? If so, what was your experience like?
Log in to reply.